Severity and risk ofCOVID‐19 in cancer patients: An evidence‐based learning
Dermatologic Therapy2020Vol. 33(5), pp. e13778–e13778
Citations Over TimeTop 20% of 2020 papers
Abstract
The immune system of cancer patient gets compromised because of cancer therapy, surgery, and malignancy and thus the probability of infection are increased than the general patients. Immunosuppression can expose cancer patients to serious complications which can lead to delay in diagnosis and unnecessary hospitalizations that may adversely affect the prognosis of the disease. Patients who received chemotherapy or surgery within the 30 days before novel coronavirus disease pandemic have more risk of infection than the patients who had not undergone chemotherapy or surgery.
Related Papers
- → Current Use of Immunosuppression in Liver Transplantation(2023)3 cited
- → Immunosuppression after pediatric liver transplant: The parents’ perspective(2023)3 cited
- Individual immunosuppression regime in liver transplant recipients with high risk factors(2003)
- [The mechanism of immunosuppression in tumor-bearing mice--different susceptibility of various immune responses to immunosuppression and macrophage series as targets for immunosuppression (author's transl)].(1981)
- → General Principle of Immunosuppression(2013)